Targeting the Gut Microbiota for Prevention and Management of Type 2 Diabetes
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(22), P. 3951 - 3951
Published: Nov. 19, 2024
Type
2
diabetes
(T2D)
is
a
chronic
metabolic
disorder
with
heterogeneous
etiology
encompassing
societal
and
behavioral
risk
factors
in
addition
to
genetic
environmental
susceptibility.
The
cardiovascular
consequences
of
account
for
more
than
two-thirds
mortality
among
people
T2D.
Not
only
does
T2D
shorten
life
expectancy,
but
it
also
lowers
quality
associated
extremely
high
health
expenditures
since
diabetic
complications
raise
both
direct
indirect
healthcare
costs.
An
increasing
body
research
indicates
connection
between
gut
microbial
traits,
as
numerous
alterations
the
intestinal
microorganisms
have
been
noted
pre-diabetic
individuals.
These
include
pro-inflammatory
bacterial
patterns,
increased
permeability,
endotoxemia,
hyperglycemia-favoring
conditions,
such
alteration
glucagon-like
peptide-1
(GLP-1)
secretion.
Restoring
homeostasis
can
be
very
beneficial
preventing
co-treating
improving
antidiabetic
therapy
outcomes.
This
review
summarizes
characteristics
"diabetic"
microbiota
metabolites
produced
by
species
that
worsen
or
ameliorate
progression,
suggesting
microbiota-targeted
strategies
restore
eubiosis
regulate
blood
glucose.
Nutritional
supplementation,
diet,
physical
exercise
are
known
play
important
roles
T2D,
here
their
effects
on
discussed,
non-pharmacological
approaches
greatly
help
management
highlighting
importance
tailoring
treatments
individual
needs.
Language: Английский
New C-linked diarylheptanoid dimers as potential α-glucosidase inhibitors evidenced by biological, spectral and theoretical approaches
Xinyu Li,
No information about this author
Tian Wang,
No information about this author
Sheng‐Li Wu
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
295, P. 139496 - 139496
Published: Jan. 7, 2025
Language: Английский
Diabetes and Sarcopenia: Intersection of Co Morbid Conditions
OBM Geriatrics,
Journal Year:
2025,
Volume and Issue:
09(01), P. 1 - 23
Published: Feb. 20, 2025
Sarcopenia
is
more
common
in
persons
with
type
2
diabetes
mellitus
(T2DM)
than
without
diabetes.
There
overlap
of
some
pathophysiologic
features
sarcopenia
and
T2DM.
In
addition,
the
risk
for
associated
complications
T2DM
including
renal
disease,
cardiovascular
disease
neuropathy.
Glycemic
control
may
have
benefits
on
sarcopenia.
The
specific
effects
glucose
lowering
agents
suggest
that
metformin,
insulin,
thiazolidinediones
GLP1
receptor
agonists
favorable
while
SGLT2
inhibitors
an
adverse
effect.
However,
RA’s
been
outcomes
increased
heart
failure.
Thus
risk/benefit
ratio
overall
key
to
selection
agents.
Nutrition
guidelines
generally
align
recommendations
Data
aerobic
resistance
exercise
patients
very
limited,
but
data
a
benefit
exercises.
Language: Английский
Validation of the Persian version of the summary of diabetes self-care activities scale (SDSCA) in pregnant women with gestational diabetes mellitus using a COSMIN methodology
BMC Endocrine Disorders,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: April 18, 2025
Gestational
diabetes
mellitus
(GDM)
is
a
condition
with
significant
prenatal
and
postnatal
implications.
This
study
aimed
to
validate
the
Summary
of
Diabetes
Self-Care
Activities
(SDSCA)
measure
in
Iranian
women
GDM,
focusing
on
its
psychometric
properties.
The
Persian
version
SDSCA
was
evaluated
180
GDM.
Following
COSMIN
guidelines,
instrument
translated
into
Persian,
properties
were
assessed,
including
content
validity,
face
construct
internal
consistency,
test-retest
reliability,
measurement
error,
responsiveness,
interpretability.
Floor
ceiling
effects
also
examined.
validity
assessments
showed
strong
Content
Validity
Index
(CVI)
0.93
Ratio
(CVR)
0.97.
Face
yielded
an
impact
score
4.38.
Exploratory
factor
analysis
(EFA)
identified
three
factors-diet,
exercise,
blood
sugar
testing-accounting
for
57.4%
variance.
Confirmatory
(CFA)
confirmed
model's
excellent
fit
(CFI
=
1.00,
TLI
0.99,
NFI
0.98,
RFI
0.96).
reliability
Cronbach's
alpha
0.78
McDonald's
omega
0.91,
intraclass
correlation
coefficient
(ICC)
0.92
(95%
CI:
0.83-0.96).
Ceiling
observed
testing
(26.7%),
while
floor
noted
exercise
(6.7%)
(6.1%).
Minimal
Important
Change
(MIC)
2.68
units
exceeded
Smallest
Detectable
(SDC)
1.11
units,
indicating
tool's
ability
detect
clinically
meaningful
changes.
demonstrates
properties,
both
making
it
suitable
tool
assessing
self-care
behaviors
Its
use
future
research
can
enhance
understanding
self-management
this
population.
Language: Английский
Advanced Glycation End Products in Disease Development and Potential Interventions
Yihan Zhang,
No information about this author
Zhen Zhang,
No information about this author
Chuyue Tu
No information about this author
et al.
Antioxidants,
Journal Year:
2025,
Volume and Issue:
14(4), P. 492 - 492
Published: April 18, 2025
Advanced
glycation
end
products
(AGEs)
are
a
group
of
compounds
formed
through
non-enzymatic
reactions
between
reducing
sugars
and
proteins,
lipids,
or
nucleic
acids.
AGEs
can
be
generated
in
the
body
introduced
dietary
sources
smoking.
Recent
clinical
animal
studies
have
highlighted
significant
role
various
health
conditions.
These
accumulate
nearly
all
mammalian
tissues
associated
with
range
diseases,
including
diabetes
its
complications,
cardiovascular
disease,
neurodegeneration.
This
review
summarizes
major
diseases
linked
to
AGE
accumulation,
presenting
both
experimental
evidence.
The
pathologies
induced
by
share
common
mechanisms
across
different
organs,
primarily
involving
oxidative
stress,
chronic
inflammation,
direct
protein
cross-linking.
Interventions
targeting
AGE-related
focus
on
inhibiting
formation
using
synthetic
natural
antioxidants,
as
well
intake
lifestyle
modifications.
recognized
risk
factors
that
impact
accelerate
aging,
particularly
individuals
hyperglycemia.
Monitoring
level
implementing
nutritional
interventions
help
maintain
overall
reduce
complications.
Language: Английский
A new perspective of blood routine test for the prediction and diagnosis of hyperglycemia
BMC Endocrine Disorders,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: April 25, 2025
The
presence
of
hyperglycemia
induces
alterations
in
the
blood
cell
microenvironment.
However,
further
investigations
are
warranted
to
comprehend
regulation
physiological
parameter
changes
within
hyperglycemic
cohort
and
validate
their
correlation.
This
study
aims
investigate
correlation
between
peripheral
parameters,
providing
valuable
insights
for
screening
treatment
hyperglycemia.
A
retrospective
was
conducted
analyze
demographic
characteristics
routine
test
(blood
RT)
results
both
normal
population
individuals
with
distribution
abnormal
RT
compared
groups
group.
Univariate
multivariate
logistic
regression
analyses
were
employed
levels
In
addition,
stored
red
cells
(RBCs)
placed
high
glucose
concentration
low
environment,
parameters
RBCs
observed
after
35
days
storage.
included
a
total
413
participants,
202
representing
population.
Among
these,
there
95
males
(47.03%)
107
females
(52.97%).
group
consisted
impaired
tolerance
(IGT)
diabetes
mellitus
(DM).
Out
sample,
61
participants
IGT,
consisting
45
(73.77%)
16
(26.23%).
Additionally,
150
DM,
including
(71.33%)
43
(28.67%).
prevalence
showed
significant
increase
among
aged
over
years
(p
<
0.05).
white
count
(WBC),
(RBC),
hemoglobin
(HGB),
hematocrit
(HCT),
mean
corpuscular
volume
(MCV),
(MCHC)
significantly
higher
than
those
revealed
that
DM
had
highest
proportion
WBC,
while
IGT
exhibited
proportions
RBC,
HGB,
HCT
analysis
WBC
(odds
ratio
[OR],
1.422;
95%
CI,
1.249-1.631),
RBC
(OR,
2.163;
1.449-3.270),
HGB
1.033;
1.020-1.047),
4.549;
0.569-8.591),
MCH
1.175;
1.057-1.319),
MCHC
1.071;
1.047-1.098)
predictor
indices
Multivariate
1.434;
1.193-1.742)
4.448;
0.084-237.9)
vitro
experiments
demonstrated
decreased
MCV,
concurrently
increasing
coefficient
variation
width
(RDW-CV)
present
correlations
gender,
age,
as
well
certain
parameters.
Moreover,
provided
support
these
associations.
Consequently,
can
serve
prevention,
offering
essential
enhance
preventive
strategies.
Language: Английский
The Anti-atherosclerotic Effects of Endothelin Receptor Antagonist, Bosentan, in Combination with Atorvastatin – an Experimental Study
Published: May 14, 2024
Bosentan,
an
endothelin-receptor
antagonist
(ERA),
has
potential
anti-atherosclerotic
properties.
We
investigated
the
complementary
effects
of
bosentan
and
atorvastatin
on
progression
composition
atherosclerotic
lesions
in
diabetic
mice.
Forty-eight
male
apoE-/-
mice
were
fed
high-fat
diet
(HFD)
for
14
weeks.
At
week
8,
diabetes
was
induced
with
streptozotocin
randomized
into
4
groups:
1)
Control/COG:
no
intervention.
2)
ΒΟG:
100
mg/kg/day
per
os.
3)
ATG:
20mg/kg/day
os).
4)
BO+ATG:
Combined
administration
atorvastatin.
The
intra-plaque
contents
collagen,
elastin,
monocyte
chemoattractant
protein-1
(MCP-1),
tumor
necrosis
factor-a
(TNF-a),
matrix-metalloproteinases
(MMP-2,-3,-9),
TIMP-1
concentrations
determined.
percentage
lumen
stenosis
significantly
decreased
across
all
treated
BOG:
19.5±2.2%,
12.8±4.8%,
9.1±2.7%
compared
to
controls
(24.6±4.8%,
p&lt;0.001).
Both
increased
collagen
content
fibrous
cap
thickness
versus
COG
(p&lt;0.01).
All
intervention
groups
reduced
relative
MCP-1,
MMP-3,-9,
(p&lt;0.001).
Importantly,
showed
modest
but
additive
latter
parameters
(p&lt;0.05).
Bosentan
treatment
diabetic,
delayed
atherosclerosis
enhanced
plaques’
stability,
showing
atorvastatin,
which
are
promising
cardiovascular
diseases.
Language: Английский
The Anti-Atherosclerotic Effects of Endothelin Receptor Antagonist, Bosentan, in Combination with Atorvastatin—An Experimental Study
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(12), P. 6614 - 6614
Published: June 16, 2024
Bosentan,
an
endothelin
receptor
antagonist
(ERA),
has
potential
anti-atherosclerotic
properties.
We
investigated
the
complementary
effects
of
bosentan
and
atorvastatin
on
progression
composition
atherosclerotic
lesions
in
diabetic
mice.
Forty-eight
male
ApoE-/-
mice
were
fed
high-fat
diet
(HFD)
for
14
weeks.
At
week
8,
diabetes
was
induced
with
streptozotocin,
randomized
into
four
groups:
(1)
control/COG:
no
intervention;
(2)
ΒOG:
100
mg/kg/day
per
os;
(3)
ATG:
20
(4)
BO
+
combined
administration
atorvastatin.
The
intra-plaque
contents
collagen,
elastin,
monocyte
chemoattractant
protein-1
(MCP-1),
tumor
necrosis
factor-a
(TNF-a),
matrix
metalloproteinases
(MMP-2,
-3,
-9),
TIMP-1
determined.
percentage
lumen
stenosis
significantly
lower
across
all
treated
BOG:
19.5
±
2.2%,
12.8
4.8%,
9.1
2.7%
compared
to
controls
(24.6
p
<
0.001).
both
resulted
higher
collagen
content
thicker
fibrous
cap
versus
COG
(p
0.01).
All
intervention
groups
showed
relative
concentrations
MCP-1,
MMP-3,
MMP-9
a
TIMP-1concentration
Importantly,
latter
parameters
presented
levels
when
0.05).
Bosentan
treatment
diabetic,
delayed
atherosclerosis
enhanced
plaques'
stability,
showing
modest
but
additive
atorvastatin,
which
are
promising
cardiovascular
diseases.
Language: Английский
Effect of Different Rates of Rambutan Peel Extract on Visfatin and Cardiac Troponin I Response in Type 2 Diabetic Rats Induced with Streptozotocin
Indian Journal of Animal Research,
Journal Year:
2024,
Volume and Issue:
Of
Published: Nov. 12, 2024
Background:
The
aim
of
this
study
was
to
investigate
the
effects
STZ
(Streptozotocin)
and
Rambutan
peel
extract
(RPE)
on
serum
visfatin
cardiac
response
in
experimental
Type
2
diabetic
rats.
Methods:
In
study,
64
adult
male
Wistar
albino
rats,
aged
between
8-10
weeks,
were
used.
8
groups
randomly
selected,
each
containing
rats
as
Control
(C),
R100
(RPE
100
mg/kg
group
given
with
oral
gavage
route
administration
(OGRA),
R200
200
OGRA),
R300
300
OGRA);
Diabetes
(DC):
50
i.p
administered
group,
DR100
(D+100
JPE),
DR200
(D+200
DR300
(D+300
JPE).
lasted
a
total
31
days,
including
adaptation
(7
days),
induction
diabetes
(3
trial
period
(21
days).
Blood
samples
taken
from
tail
vein
(vena
caudalis)
all
subjects
days
0
21
study.
Visfatin
cTnI
levels
measured
evaluated
by
ELISA
method.
Result:
While
increase
mean
seen
mostly
DC
groups,
most
significant
decrease
level
due
addition
RPE
determined
(p
less
than
0.01).As
result,
it
concluded
that
had
no
adverse
effects.
It
RPE,
which
has
cardioprotective
effect
regulating
plays
role
development
diabetes,
may
be
useful
supporting
impaired
cardiovascular
system
function
occurs
diabetes.
Language: Английский